These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21530908)

  • 1. [Data transparency regarding medical devices - the position of the medical device industry].
    Soskuty G
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(3):189-93. PubMed ID: 21530908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
    Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical innovations in the area of conflict between certification and allowance].
    Möller B; Stockheim M; Kraus T; Weber A
    Dtsch Med Wochenschr; 2010 Oct; 135(42):2088-92. PubMed ID: 20941684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Options for a future-oriented innovation policy in the medical devices industry].
    Nusser M; Lindner R
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):709-14. PubMed ID: 21147432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trials with medical devices: lack of quality illustrated for faecal incontinence].
    Vonthein R; Hemmelmann C; König IR; Schwandner T; Bruch HP; Ziegler A
    Zentralbl Chir; 2012 Aug; 137(4):380-4. PubMed ID: 21739411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical doctors driving technological innovation: questions about and innovation management approaches to incentive structures for lead users].
    Bohnet-Joschko S; Kientzler F
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):721-6. PubMed ID: 21147434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; refurbishers, rebuilders, reconditioners, servicers, and "as is" remarketers of medical devices; review and revision of compliance policy guides and regulatory requirements; request for comments and information--FDA. Advance notice of proposed rulemaking.
    Fed Regist; 1997 Dec; 62(246):67011-3. PubMed ID: 10179309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of medical devices in the European Union.
    Chai J
    J Leg Med; 2000 Dec; 21(4):537-56. PubMed ID: 11194571
    [No Abstract]   [Full Text] [Related]  

  • 11. Health technology assessment for medical devices in Europe. What must be considered.
    Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
    Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; current good manufacturing practice (CGMP) final fule; quality system regulation--FDA. Final rule.
    Fed Regist; 1996 Oct; 61(195):52602-62. PubMed ID: 10168287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Food and Drug Administration and atrial defibrillation devices.
    Chen L; Keane AT; Every NR
    Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to manufacturers of blood establishment computer software products--FDA. Notice.
    Fed Regist; 1994 Aug; 59(168):44991-2. PubMed ID: 10136917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To have (medical devices) or not: what's safer for patients?
    McCormack J
    Health Facil Manage; 1995 Jun; 8(6):44, 46, 48. PubMed ID: 10142630
    [No Abstract]   [Full Text] [Related]  

  • 18. On the Way to New Horizons: Telemedicine in Oncology.
    Schlag PM
    Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
    Flaherty JM
    Food Drug Law J; 2001; 56(3):339-49. PubMed ID: 11944643
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.